You can find the annual or quarterly income statement of Artiva Biotherapeutics Inc here for insights into the performance and operational efficiency of Artiva Biotherapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q2

FY2023Q1

FY2022Q1

Total revenue

--0.00

-100.00%0.00

--0.00

-100.00%0.00

-74.62%251.00K

--3.50M

-26.63%989.00K

--1.35M

Revenue

--0.00

-100.00%0.00

--0.00

-100.00%0.00

-74.62%251.00K

--3.50M

-26.63%989.00K

--1.35M

Operating expenses

24.88%22.90M

40.89%22.81M

50.38%22.17M

--18.27M

--18.34M

5.67%16.19M

-21.06%14.74M

--15.32M

38.64%18.68M

--13.47M

R&D expenses

30.38%17.63M

44.82%17.86M

52.85%17.05M

--13.32M

--13.52M

9.51%12.33M

-24.47%11.16M

--11.26M

52.20%14.77M

--9.71M

Depreciation, depletion, and amortization

5.58%662.00K

6.30%641.00K

4.67%628.00K

--614.00K

--627.00K

12.08%603.00K

0.00%600.00K

--538.00K

259.28%600.00K

--167.00K

Operating profit

-24.88%-22.90M

-40.89%-22.81M

-52.99%-22.17M

---18.27M

---18.34M

-36.92%-16.19M

18.07%-14.49M

---11.82M

-45.89%-17.69M

---12.12M

Net non-operating interest income (expenses)

Non-operating interest income

-25.68%1.37M

130.92%1.56M

186.77%1.86M

--2.18M

--1.85M

32.81%676.00K

-36.52%650.00K

--509.00K

--1.02M

----

Special income (expenses)

100.00%0.00

--0.00

---977.00K

---2.35M

---268.00K

--0.00

Other non-operating income (expenses)

50.00%-3.00K

-121.74%-5.00K

-102.72%-4.00K

---5.00K

---6.00K

-25.81%23.00K

377.36%147.00K

--31.00K

---53.00K

----

Income before tax

-23.21%-21.53M

-19.12%-21.25M

-45.46%-20.31M

---16.09M

---17.47M

-58.13%-17.84M

16.47%-13.96M

---11.28M

-37.88%-16.72M

---12.12M

Income after tax

-23.21%-21.53M

-19.12%-21.25M

-45.46%-20.31M

---16.09M

---17.47M

-58.13%-17.84M

16.47%-13.96M

---11.28M

-37.88%-16.72M

---12.12M

Net income from continuous operations

-23.21%-21.53M

-19.12%-21.25M

-45.46%-20.31M

---16.09M

---17.47M

-58.13%-17.84M

16.47%-13.96M

---11.28M

-37.88%-16.72M

---12.12M

Net income attributable to controlling interests

-23.21%-21.53M

-19.12%-21.25M

-45.46%-20.31M

---16.09M

---17.47M

-58.13%-17.84M

16.47%-13.96M

---11.28M

-37.88%-16.72M

---12.12M

Net income attributable to common shareholders

-23.21%-21.53M

-19.12%-21.25M

-45.46%-20.31M

---16.09M

---17.47M

-58.13%-17.84M

16.47%-13.96M

---11.28M

-37.88%-16.72M

---12.12M

Basic earnings per share

4.89%-0.88

-13.76%-0.87

-39.12%-0.83

---0.66

---0.92

-58.12%-0.77

16.47%-0.60

---0.48

-37.88%-0.72

---0.52

Diluted earnings per share

4.89%-0.88

-13.76%-0.87

-39.12%-0.83

---0.66

---0.92

-58.12%-0.77

16.47%-0.60

---0.48

-37.88%-0.72

---0.52

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

